Here, we reported a Chinese patient with intrahepatic cholangiocarcinoma, a high TMB and high expression of PD-L1 who responded well to the combined therapy of pembrolizumab and chemotherapy. The gene discussed is CD274; the disease is intrahepatic cholangiocarcinoma.